Applied models and molecular characteristics of small cell lung cancer

被引:2
作者
Fur, Gabriella Mihalekne [1 ]
Nemes, Kolos [1 ]
Mago, Eva [1 ,2 ]
Beno, Alexandra A. [1 ]
Topolcsanyi, Petronella [1 ]
Moldvay, Judit [3 ,4 ]
Pongor, Lorinc S. [1 ]
机构
[1] Hungarian Ctr Excellence Mol Med HCEMM, Canc Genom & Epigenet Core Grp, Szeged, Hungary
[2] Hungarian Ctr Excellence Mol Med HCEMM, Genome Integr & DNA Repair Core Grp, Szeged, Hungary
[3] Szeged Univ, Szent Gyorgy Albert Med Sch, Dept Pulmonol, Szeged, Hungary
[4] Natl Koranyi Inst Pulmonol, Dept Pulmonol 1, Budapest, Hungary
关键词
SCLC; drug response; ctDNA; liquid biopsy; databases; CIRCULATING TUMOR-CELLS; NEUROENDOCRINE DIFFERENTIATION; PRECLINICAL MODELS; DRUG-SENSITIVITY; XENOGRAFT MODEL; GENE-THERAPY; IDENTIFICATION; HETEROGENEITY; DNA; EXPRESSION;
D O I
10.3389/pore.2024.1611743
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Small cell lung cancer (SCLC) is a highly aggressive type of cancer frequently diagnosed with metastatic spread, rendering it surgically unresectable for the majority of patients. Although initial responses to platinum-based therapies are often observed, SCLC invariably relapses within months, frequently developing drug-resistance ultimately contributing to short overall survival rates. Recently, SCLC research aimed to elucidate the dynamic changes in the genetic and epigenetic landscape. These have revealed distinct subtypes of SCLC, each characterized by unique molecular signatures. The recent understanding of the molecular heterogeneity of SCLC has opened up potential avenues for precision medicine, enabling the development of targeted therapeutic strategies. In this review, we delve into the applied models and computational approaches that have been instrumental in the identification of promising drug candidates. We also explore the emerging molecular diagnostic tools that hold the potential to transform clinical practice and patient care.
引用
收藏
页数:13
相关论文
共 131 条
[1]   Circulating tumor cells as a predictive biomarker in patients with small cell lung cancer undergoing chemotherapy [J].
Aggarwal, Charu ;
Wang, Xingmei ;
Ranganathan, Anjana ;
Torigian, Drew ;
Troxel, Andrea ;
Evans, Tracey ;
Cohen, Roger B. ;
Vaidya, Bhavesh ;
Rao, Chandra ;
Connelly, Mark ;
Vachani, Anil ;
Langer, Corey ;
Albelda, Steven .
LUNG CANCER, 2017, 112 :118-125
[2]   Longitudinal Cell-Free DNA Analysis in Patients with Small Cell Lung Cancer Reveals Dynamic Insights into Treatment Efficacy and Disease Relapse [J].
Almodovar, Karinna ;
Iams, Wade T. ;
Meador, Catherine B. ;
Zhao, Zhiguo ;
York, Sally ;
Horn, Leora ;
Yan, Yingjun ;
Hernandez, Jennifer ;
Chen, Heidi ;
Shyr, Yu ;
Lim, Lee P. ;
Raymond, Christopher K. ;
Lovly, Christine M. .
JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (01) :112-123
[3]   The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity [J].
Barretina, Jordi ;
Caponigro, Giordano ;
Stransky, Nicolas ;
Venkatesan, Kavitha ;
Margolin, Adam A. ;
Kim, Sungjoon ;
Wilson, Christopher J. ;
Lehar, Joseph ;
Kryukov, Gregory V. ;
Sonkin, Dmitriy ;
Reddy, Anupama ;
Liu, Manway ;
Murray, Lauren ;
Berger, Michael F. ;
Monahan, John E. ;
Morais, Paula ;
Meltzer, Jodi ;
Korejwa, Adam ;
Jane-Valbuena, Judit ;
Mapa, Felipa A. ;
Thibault, Joseph ;
Bric-Furlong, Eva ;
Raman, Pichai ;
Shipway, Aaron ;
Engels, Ingo H. ;
Cheng, Jill ;
Yu, Guoying K. ;
Yu, Jianjun ;
Aspesi, Peter, Jr. ;
de Silva, Melanie ;
Jagtap, Kalpana ;
Jones, Michael D. ;
Wang, Li ;
Hatton, Charles ;
Palescandolo, Emanuele ;
Gupta, Supriya ;
Mahan, Scott ;
Sougnez, Carrie ;
Onofrio, Robert C. ;
Liefeld, Ted ;
MacConaill, Laura ;
Winckler, Wendy ;
Reich, Michael ;
Li, Nanxin ;
Mesirov, Jill P. ;
Gabriel, Stacey B. ;
Getz, Gad ;
Ardlie, Kristin ;
Chan, Vivien ;
Myer, Vic E. .
NATURE, 2012, 483 (7391) :603-607
[4]   Targeting DNA Replication Stress and DNA Double-Strand Break Repair for Optimizing SCLC Treatment [J].
Bian, Xing ;
Lin, Wenchu .
CANCERS, 2019, 11 (09)
[5]   An achaete-scute homologue essential for neuroendocrine differentiation in the lung [J].
Borges, M ;
Linnoila, RI ;
vandeVelde, HJK ;
Chen, H ;
Nelkin, BD ;
Mabry, M ;
Baylin, SB ;
Ball, DW .
NATURE, 1997, 386 (6627) :852-855
[6]   ASCL1 and NEUROD1 Reveal Heterogeneity in Pulmonary Neuroendocrine Tumors and Regulate Distinct Genetic Programs [J].
Borromeo, Mark D. ;
Savage, Trisha K. ;
Kollipara, Rahul K. ;
He, Min ;
Augustyn, Alexander ;
Osborne, Jihan K. ;
Girard, Luc ;
Minna, John D. ;
Gazdar, Adi F. ;
Cobb, Melanie H. ;
Johnson, Jane E. .
CELL REPORTS, 2016, 16 (05) :1259-1272
[7]   Family matters: How MYC family oncogenes impact small cell lung cancer [J].
Braegelmann, Johannes ;
Boehm, Stefanie ;
Guthrie, Matthew R. ;
Mollaoglu, Gurkan ;
Oliver, Trudy G. ;
Sos, Martin L. .
CELL CYCLE, 2017, 16 (16) :1489-1498
[8]   The European Nucleotide Archive in 2022 [J].
Burgin, Josephine ;
Ahamed, Alisha ;
Cummins, Carla ;
Devraj, Rajkumar ;
Gueye, Khadim ;
Gupta, Dipayan ;
Gupta, Vikas ;
Haseeb, Muhammad ;
Ihsan, Maira ;
Ivanov, Eugene ;
Jayathilaka, Suran ;
Kadhirvelu, Vishnukumar Balavenkataraman ;
Kumar, Manish ;
Lathi, Ankur ;
Leinonen, Rasko ;
Mansurova, Milena ;
McKinnon, Jasmine ;
O'Cathail, Colman ;
Pauperio, Joana ;
Pesant, Stephane ;
Rahman, Nadim ;
Rinck, Gabriele ;
Selvakumar, Sandeep ;
Suman, Swati ;
Vijayaraja, Senthilnathan ;
Waheed, Zahra ;
Woollard, Peter ;
Yuan, David ;
Zyoud, Ahmad ;
Burdett, Tony ;
Cochrane, Guy .
NUCLEIC ACIDS RESEARCH, 2023, 51 (D1) :D121-D125
[9]   Protein expression of TTF1 and cMYC define distinct molecular subgroups of small cell lung cancer with unique vulnerabilities to aurora kinase inhibition, DLL3 targeting, and other targeted therapies [J].
Cardnell, Robert J. ;
Li, Lerong ;
Sen, Triparna ;
Bara, Rasha ;
Tong, Pan ;
Fujimoto, Junya ;
Ireland, Abbie S. ;
Guthrie, Matthew R. ;
Bheddah, Sheila ;
Banerjee, Upasana ;
Kalu, Nene N. ;
Fan, You-Hong ;
Dylla, Scott J. ;
Johnson, Faye M. ;
Wistuba, Ignacio I. ;
Oliver, Trudy G. ;
Heymach, John V. ;
Glisson, Bonnie S. ;
Wang, Jing ;
Byers, Lauren A. .
ONCOTARGET, 2017, 8 (43) :73419-73432
[10]  
CARNEY DN, 1980, CANCER RES, V40, P1820